2023
DOI: 10.1002/acm2.14091
|View full text |Cite
|
Sign up to set email alerts
|

FLASH instead of proton arc therapy is a more promising advancement for the next generation proton radiotherapy

Abstract: Minglei Kang and Xuanfeng Ding contributed equally to the manuscript.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 86 publications
0
2
0
Order By: Relevance
“…The long-term effects of FLASH are not yet well-known; FLASH is a new treatment approach, and thus, not many patients have been treated with the new techniques [21]. As new studies are conducted and current research advances, the long-term effects, if any, will become evident within a decade or two [22,23].…”
Section: Background Of Flash Radiotherapymentioning
confidence: 99%
“…The long-term effects of FLASH are not yet well-known; FLASH is a new treatment approach, and thus, not many patients have been treated with the new techniques [21]. As new studies are conducted and current research advances, the long-term effects, if any, will become evident within a decade or two [22,23].…”
Section: Background Of Flash Radiotherapymentioning
confidence: 99%
“…Proton arc therapy (PAT) is an emerging radiation therapy treatment technique delivering the protons in pencil beam scanning mode while the gantry moves, as opposed to intensity modulated proton therapy (IMPT) where the gantry is stationary while irradiating. One of the perceived improvements of PAT over IMPT is its reduced delivery time (Kang et al 2023), however there is no publicly open algorithm to estimate the delivery time of PAT plans. Therefore, optimization algorithms for creating PAT treatment plans often try to reduce the delivery time indirectly by reducing the number of energy switches to higher energies (Gu et al 2020, Liu et al 2020, Engwall et al 2022.…”
Section: Introductionmentioning
confidence: 99%
“…16 Most recently, adaptive radiotherapy (ART) 17 and biological guided radiotherapy (BGRT) 18,19 have improved the precision of radiotherapy, but there is still a long way to go before reaching the cellular level achievable compared to chemodynamic therapy. Advancements in radiobiology, such as the immunological effects resulting from hypofractionation and stereotactic body radiotherapy (SBRT), 20,21 safety assurances for normal tissues provided by spatial fractionation radiotherapy (SFRT) 2 2 and ultrahigh dose rate radiotherapy (FLASH), 23,24 and particle therapies like protons and heavy ions, offer enhanced linear energy transfer (LET) and relative biological effectiveness (RBE), 25 highlighting the trend of combining radiotherapy with synergistic antitumor therapies like chemotherapy and immunotherapy. 15,26 Considering the limitations of current radiotherapy in terms of precision, excellent research work has focused on the fancy radiosensitive strategy, including combined tumor therapy mediated by supramolecular options and liposome 27−29 or exogenous energy.…”
Section: Introductionmentioning
confidence: 99%